Literature DB >> 4978906

Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

B S Blumberg, J S Friedlaender, A Woodside, A I Sutnick, W T London.   

Abstract

Examples of inherited susceptibility to infection controlled by genes segregating at one or a small number of loci have been identified in lower animals. In this study we report data on what appears to be a similar situation in humans. "Australia antigen" is an antigen found in the sera of patients with acute and chronic hepatitis, and it may actually be a form of virus. It is very common in many tropical areas, and people in these areas having the antigen appear to be hepatitis carriers. The antigen is detected by immuno-diffusion in agar gel (Ouchterlony method). Individuals with the antigen are designated Au(1) and those without it Au(0). Family studies involving 1797 different individuals residing on the island of Bougainville are consistent with the hypothesis that susceptibility to chronic infection with the "antigen" is controlled by an autosomal recessive gene (Au(1)). This confirms the conclusions previously arrived at from similar (but less extensive) studies on the island of Cebu. Individuals with this inherited susceptibility do not ordinarily have overt manifestations of hepatitis. The sign test was used to determine family clustering. Segregation analysis was performed by the method of C. A. B. Smith. In the 41 Au(0) x Au(0) matings, 53.8 recessives were expected in the offspring and 56 were seen (0.7 > p > 0.5). In the Au(1) x Au(0) matings, 40.1 recessives were expected and 42 were seen (0.7 > p > 0.5). The Au(0) x Au(0) matings were also analyzed by the method of Li and Mantel, in which the recessive ratio of 0.25 is expected by the genetic hypothesis. The values observed were 0.2527 for the Bougainville study and 0.2461 for the Cebu study.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4978906      PMCID: PMC223621          DOI: 10.1073/pnas.62.4.1108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome.

Authors:  A I Sutnick; W T London; B J Gerstley; M M Cronlund; B S Blumberg
Journal:  JAMA       Date:  1968-09-02       Impact factor: 56.272

2.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

3.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

4.  Inheritance of resistance to polyoma tumorigenesis in inbred mice.

Authors:  M Jahkola
Journal:  J Natl Cancer Inst       Date:  1965-10       Impact factor: 13.506

5.  Some experimental evidence for the influence of genetic factors on viral leukemogenesis.

Authors:  J R Tennant; G D Snell
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

6.  Relation of Australia and SH antigens.

Authors:  A M Prince
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

7.  Family studies of a human serum isoantigen system (Australia antigen).

Authors:  B S Blumberg; L Melartin; R A Guint; B Werner
Journal:  Am J Hum Genet       Date:  1966-11       Impact factor: 11.025

8.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

9.  A simple method of estimating the segregation ratio under complete ascertainment.

Authors:  C C Li; N Mantel
Journal:  Am J Hum Genet       Date:  1968-01       Impact factor: 11.025

10.  Production of antibody against "Australia antigen" in rabbits.

Authors:  L Melartin; B S Blumberg
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

View more
  35 in total

Review 1.  Epidemiology of viral hepatitis B in the tropics.

Authors:  T I Francis
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  Host susceptibility to persistent hepatitis B virus infection.

Authors:  Ying-Li He; Ying-Ren Zhao; Shu-Lin Zhang; Shu-Mei Lin
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Immunological studies of Australia antigen carriers with and without liver diseases.

Authors:  J O Nielsen; V Reinicke; O Dietrichson; V Andersen; M Thomsen; E Andersen
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

4.  Immunological studies in Ugandan patients with hepatocellular carcinoma.

Authors:  A Primack; C L Vogel; L F Barker
Journal:  Br Med J       Date:  1973-01-06

Review 5.  Hepatitis-associated (Australia) antigen: a review.

Authors:  J B Simon
Journal:  Can Med Assoc J       Date:  1971-09-18       Impact factor: 8.262

6.  Australia antigen: persistence of immunological markers (d, y, w) in antigen carriers.

Authors:  S Mazzur; B S Blumberg
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

Review 7.  [Problems associated with transfusion of post mortem blood].

Authors:  P Volk; J G Gostomzyk; B Schäfer; R Reck
Journal:  Z Rechtsmed       Date:  1970

8.  Lack of supportive evidence for an autosomal recessive inheritance in chronic hepatitis B infections.

Authors:  M J Tong; J M Weiner
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

9.  [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].

Authors:  J Knolle; M Born; G Hess; O Klinge; W Arnold; H Bitz; K H Meyer
Journal:  Klin Wochenschr       Date:  1976-06-15

10.  Familial clustering of hepatitis B antigen: a study in relatives of patients with liver diseases and hepatitis B antigenaemia.

Authors:  M Bruguera; J Bosch; J Rodés; J Pedreira
Journal:  Br Med J       Date:  1974-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.